Galectin-9-driven immune evasion constrains radiotherapy-induced systemic antitumor immunity
Jiaming Song(Tianjin Medical University Cancer Institute and Hospital), Linlin Sun(Guangxi Medical University), Boning Liu(Chinese Academy of Sciences), Qihui Chen(Tianjin Medical University General Hospital), Mien‐Chie Hung(Precision Therapeutics (United States)), Cheng‐En Hsieh(Chang Gung Memorial Hospital), Zhiguo Liu(Nanjing University), Delong Liu(National Institute of Diabetes and Digestive and Kidney Diseases), Hsiao‐Fan Chen(China Medical University), Riyao Yang(The University of Texas MD Anderson Cancer Center), Shasha Shi(Tianjin Medical University General Hospital), Shunjie Xiong(Tianjin Medical University General Hospital), Jinjian Liu(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 0
Related Papers
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
|Cancer Cell|2004|1.9k
Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity
|Nature Communications|2016|1.1k
STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
|Nature Communications|2018|427
Danazol Treatment for Telomere Diseases
|New England Journal of Medicine|2016|401
IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion
|Journal of Clinical Investigation|2019|380